A novel acridine flow cytometry marker to track post‐transfusion amustaline/glutathione pathogen‐reduced red blood cell survival in sickle cell disease patients

Documenti analoghi

• Survival of transfused red blood cells from a donor with alpha‐thalassemia trait in a recipient with sickle cell disease
  di: Marianne E. M. Yee, et al.
  Pubblicazione: (2024)
• Transfusion utilization during gene therapy for sickle cell disease: A single institution experience
  di: Ross M. Fasano, et al.
  Pubblicazione: (2026)
• Amustaline/glutathione pathogen‐reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trial
  di: Ian J. Welsby, et al.
  Pubblicazione: (2025)
• RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA
  di: Narek Israelyan, et al.
  Pubblicazione: (2024)
• Adding hydroxyurea to chronic transfusion therapy for sickle cell anemia reduces transfusion burden
  di: Robert Sheppard Nickel, et al.
  Pubblicazione: (2024)